# An Active-controlled, Clinical Trial to Assess Central Hemodynamic Effects of Bisoprolol in Hypertensive Patients (Central Hemodynamic Assessment Measured in Patient With HypertensION [CHAMPION])

> **NCT01079962** · PHASE4 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 209 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Bisoprolol
- **DRUG:** Atenolol

## Key facts

- **NCT ID:** NCT01079962
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 209 (ACTUAL)
- **Last updated:** 2014-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01079962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01079962, "An Active-controlled, Clinical Trial to Assess Central Hemodynamic Effects of Bisoprolol in Hypertensive Patients (Central Hemodynamic Assessment Measured in Patient With HypertensION [CHAMPION])". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01079962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*